Aarti Pharmalabs Ltd.

Financial

	Aarti Pharmalabs	Shilpa Medicare	Supriya Lifescience
Operational Metrics
Financials
5 yr Average ROE	7.89 %	5.0 %	29.47 %
5yr average Equity Multiplier	1.37	1.64	1.48
5yr Average Asset Turnover Ratio	0.54	0.39	0.74
5yr Avg Net Profit Margin	7.96 %	7.72 %	24.83 %
Price to Book	3.68	3.03	6.28
P/E	27.42	80.02	32.6
5yr Avg Cash Conversion Cycle	89.79 Days	76.54 Days	10.2 Days
Inventory Days	92.09 Days	105.79 Days	54.74 Days
Days Receivable	95.5 Days	113.53 Days	55.39 Days
Days Payable	69.05 Days	120.58 Days	115.12 Days
5yr Average Interest Coverage Ratio	11.46	11.52	36.33
5yr Avg ROCE	10.86 %	6.65 %	37.03 %
5yr Avg Operating Profit Margin	13.88 %	17.76 %	34.97 %
5 yr average Debt to Equity	0.15	0.44	0.17
5yr CAGR Net Profit	n/a	-27.23 %	10.17 %
5yr Average Return on Assets	5.29 %	3.1 %	18.81 %
Shareholdings
Promoter Holding	44.29 %	44.23 %	68.3 %
Share Pledged by Promoters	0.0	7.92 %	0.0
Change in Promoter Holding (3 Yrs)	-1.69 %	-5.78 %	0.06 %
Change in Mutual Fund Holding (3 Yrs)	-4.33 %	3.04 %	-2.68 %

Business

	Aarti Pharmalabs	Shilpa Medicare	Supriya Lifescience
Product Wise Break-Up	Product Wise Break-Up Xanthine 44.1 API 43.2 CDMO 12.7 Power sales 0 Pharmaceutical product and services 0 Pharmaceuticals 0	Product Wise Break-Up CDMO 0 API 0 Pharmaceuticals 0 Power sales 0 Xanthine 0 Pharmaceutical 100.0	Product Wise Break-Up CDMO 0 API 0 Pharmaceuticals 100.0 Power sales 0 Xanthine 0 Pharmaceutical product and services 0
Location Wise Break-Up	Location Wise Break-Up India 56.0 Rest of the World 0 Europe 0 USA 0 North America 0 LAC 0 Others 44.0	Location Wise Break-Up India 5.08 Rest of the World 14.41 North America 0 Europe 29.66 LAC 0 USA 11.86 Others 38.99	Location Wise Break-Up India 0 Rest of the World 0 North America 3.0 Europe 40.0 Latin America 21.0 USA 0 Others 36.0
Customer Segment	Customer Segment Home and Personal care 100.0	-	-